A simple, safe and sensitive method for SARS-CoV-2 inactivation and RNA extraction for RT-qPCR
- PMID: 33730407
- PMCID: PMC8250463
- DOI: 10.1111/apm.13123
A simple, safe and sensitive method for SARS-CoV-2 inactivation and RNA extraction for RT-qPCR
Abstract
The SARS-CoV-2 pandemic has created an urgent need for diagnostic tests to detect viral RNA. Commercial RNA extraction kits are often expensive, in limited supply, and do not always fully inactivate the virus. Together, this calls for the development of safer methods for SARS-CoV-2 extraction that utilize readily available reagents and equipment present in most standard laboratories. We optimized and simplified a RNA extraction method combining a high molar acidic guanidinium isothiocyanate (GITC) solution, phenol and chloroform. First, we determined the GITC/RNA dilution thresholds compatible with an efficient two-step RT-qPCR for B2M mRNA in nasopharyngeal (NP) or oropharyngeal (OP) swab samples. Second, we optimized a one-step RT-qPCR against SARS-CoV-2 using NP and OP samples. We furthermore tested a SARS-CoV-2 dilution series to determine the detection threshold. The method enables downstream detection of SARS-CoV-2 by RT-qPCR with high sensitivity (~4 viral RNA copies per RT-qPCR). The protocol is simple, safe, and expands analysis capacity as the inactivated samples can be used in RT-qPCR detection tests at laboratories not otherwise classified for viral work. The method takes about 30 min from swab to PCR-ready viral RNA and circumvents the need for commercial RNA purification kits.
Keywords: RNA extraction; RT-qPCR; SARS-CoV-2; SARS-CoV-2 RT-qPCR; clinical microbiology; molecular microbiology; rapid diagnostic methods; virology; virus inactivation.
© 2021 The Authors. APMIS published by John Wiley & Sons Ltd on behalf of Scandinavian Societies for Medical Microbiology and Pathology.
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Comparison of SARS-CoV-2 indirect and direct RT-qPCR detection methods.Virol J. 2021 May 17;18(1):99. doi: 10.1186/s12985-021-01574-4. Virol J. 2021. PMID: 34001180 Free PMC article.
-
Comparative effects of viral-transport-medium heat inactivation upon downstream SARS-CoV-2 detection in patient samples.J Med Microbiol. 2021 Mar;70(3):001301. doi: 10.1099/jmm.0.001301. Epub 2021 Mar 18. J Med Microbiol. 2021. PMID: 33734960 Free PMC article.
-
Accuracy of a RT-qPCR SARS-CoV-2 detection assay without prior RNA extraction.J Virol Methods. 2021 Jan;287:113969. doi: 10.1016/j.jviromet.2020.113969. Epub 2020 Sep 9. J Virol Methods. 2021. PMID: 32918932 Free PMC article.
-
Recent progress on rapid SARS-CoV-2/COVID-19 detection by CRISPR-Cas13-based platforms.Drug Discov Today. 2021 Aug;26(8):2025-2035. doi: 10.1016/j.drudis.2021.06.005. Epub 2021 Jun 18. Drug Discov Today. 2021. PMID: 34147688 Free PMC article. Review.
-
Preanalytical Issues and Cycle Threshold Values in SARS-CoV-2 Real-Time RT-PCR Testing: Should Test Results Include These?ACS Omega. 2021 Mar 6;6(10):6528-6536. doi: 10.1021/acsomega.1c00166. eCollection 2021 Mar 16. ACS Omega. 2021. PMID: 33748564 Free PMC article. Review.
Cited by
-
Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity.Clin Lab Med. 2022 Jun;42(2):261-282. doi: 10.1016/j.cll.2022.02.006. Epub 2022 Mar 8. Clin Lab Med. 2022. PMID: 35636826 Free PMC article. Review.
-
Rapid, Portable, and Electricity-free Sample Extraction Method for Enhanced Molecular Diagnostics in Resource-Limited Settings.Anal Chem. 2024 Jul 16;96(28):11181-11188. doi: 10.1021/acs.analchem.4c00319. Epub 2024 Jul 5. Anal Chem. 2024. PMID: 38967089 Free PMC article.
References
-
- Ralph R, Lew J, Zeng T, Francis M, Xue B, Roux M, et al. 2019‐nCoV (Wuhan virus), a novel Coronavirus: human‐to‐human transmission, travel‐related cases, and vaccine readiness. J Infect Dev Ctries. 2020;14:3–17. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous